Tumor-derived erythropoietin acts as immunosuppressive switch in cancer immunity

UK researchers released first ever national strategy for cancer vaccine development, focusing on pre-cancer biology & tumor-specific proteins to create preventive vaccines. They highlight mRNA tech’s potential for personalized treatments, aligning with GSK & Oxford’s £50M cancer vaccine initiative

Scientists Pursue Cancer Vaccines Tailored to the Genetic Makeup of an Individual's Tumor

'Cancer Moonshot' Projects Funded Include Implant to Sense and Treat Cancer, Tumor-Targetting Bacteria